Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Theobromine-Based EGFRWT and EGFRT790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Processes (2022) Vol. 10, Iss. 11, pp. 2290-2290
Open Access | Times Cited: 14

Showing 14 citing articles:

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Life (2023) Vol. 13, Iss. 1, pp. 191-191
Open Access | Times Cited: 16
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1233-1250
Closed Access | Times Cited: 15
Design, in silico studies and biological evaluation of novel chalcones tethered triazolo[3,4-a]isoquinoline as EGFR inhibitors targeting resistance in non-small cell lung cancer
Nesma Abdelaal, Mohamed A. Ragheb, Hamdi M. Hassaneen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer
Eslam B. Elkaeed, Hazem Elkady, Ahmed M. Khattab, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316146-e0316146
Open Access
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282586-e0282586
Open Access | Times Cited: 13
Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents
Anas Ramadan Kotb, Abdallah E. Abdallah, Hazem Elkady, et al.
RSC Advances (2023) Vol. 13, Iss. 16, pp. 10488-10502
Open Access | Times Cited: 12
A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
ChemistryOpen (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 9
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations
Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 4214-4233
Closed Access | Times Cited: 7
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach
Eslam B. Elkaeed, Mohamed M. Khalifa, Bshra A. Alsfouk, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1122-1122
Open Access | Times Cited: 10
New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and In Vitro Studies
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 15861-15881
Open Access | Times Cited: 1
Design, synthesis, molecular docking, ADMET studies, and biological activity evaluation of new 2-({[3-aryl-1,2,4-oxadiazol-5-yl)methyl]thio}-1H-benzimidazoles and 6-amino-6-aryl-5,6-dihydro[1,6,2,4]oxathiadiazocino[4,5-a]benzimidazol-3(2H)-ones
Mohamed H. Sharaf, Amr H. Moustafa, Rami J. Obaid, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136708-136708
Closed Access | Times Cited: 3
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
Evolutionary Bioinformatics (2023) Vol. 19
Open Access | Times Cited: 2
A new anticancer derivative of the natural alkaloid, theobromine, as an EGFR inhibitor and apoptosis inducer
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Theoretical Chemistry Accounts (2023) Vol. 143, Iss. 1
Closed Access | Times Cited: 2
A Spectroscopic Approach on Permanganate Oxidation of 1-[(4-Chlorophenyl)methyl]piperidin-4-amine in Presence of Ruthenium(III) Catalyst with DFT Analysis on Reaction Mechanism Pathway
S Shashidhar, Vidyavati A. Shastry, Sampath Chinnam, et al.
Asian Journal of Chemistry (2023) Vol. 35, Iss. 12, pp. 3005-3012
Open Access
Page 1

Scroll to top